At the mRNA level and protein level, the changes in TET2 appeared to be the most conserved between HCC-SR cell lines after MenSC treatments, which was stably upregulated by MenSCs in all HCC-SR cell lines. This evidence concerns the gene TET2 and hepatocellular carcinoma.